When insomnia and obstructive sleep apnea co-occur in a condition known as COMISA, patients face a markedly elevated risk of developing type 2 diabetes. According to a new epidemiological analysis presented at the SLEEP 2026 annual meeting and a commentary published in the Journal of Clinical Sleep Medicine, this overlapping sleep pathology creates an independent cardiometabolic risk far exceeding either disorder in isolation.
In Plain English: The Clinical Takeaway
- COMISA (Comorbid Insomnia and Sleep Apnea): A condition where a patient suffers from both insomnia and obstructive sleep apnea.
- Synergistic Metabolic Burden: Rather than existing as separate issues, the combination of sleep fragmentation and nocturnal oxygen drops may act synergistically on the sympathetic nervous system, the hypothalamic-pituitary-adrenal axis, and inflammatory pathways, which are central to glucose homeostasis.
- Early Screening Imperative: Early sleep disorder identification is suggested as part of diabetes prevention efforts, especially in high-risk groups like military veterans.
The Elevated Diabetes Risk in Veterans with COMISA
The scale of this metabolic vulnerability was quantified in a large secondary data analysis of 1,074,113 U.S. military veterans, presented by Dr. Karam Al Jumaily, a clinical sleep medicine fellow at Yale University, at the SLEEP 2026 meeting in Baltimore. The research tracked participants without baseline sleep disorders or type 2 diabetes within the Department of Veterans Affairs healthcare system.
The findings illustrate a stark escalation in hazard ratios for new-onset type 2 diabetes. Insomnia alone was associated with a 41% increased risk overall, showing a 48% increase in women and 39% in men. Having sleep apnea by itself resulted in an incident diabetes risk greater than five times higher for men and approaching four times higher for women. However, patients presenting with COMISA faced an overall hazard ratio 6.2 times higher—specifically 6.5 times higher in men and 4.7 times higher in women—compared to those with neither disorder.
Among younger veterans, having both insomnia and obstructive sleep apnea was associated with a much higher risk of new-onset type 2 diabetes, well beyond the risk of either disorder alone,
Al Jumaily stated. He emphasized that these associations remained significant after adjusting for demographic, metabolic, psychiatric, and behavioral risk factors.
Mechanisms of Metabolic Disruption in COMISA
Complementing the epidemiological data, a commentary by pulmonologist Abdulghani Sankari of the John D. Dingell VA Medical Center and Wayne State University, published in the Journal of Clinical Sleep Medicine, explores the underlying physiological pathways. Drawing partly on the nationwide TURKAPNE cohort, Sankari’s analysis highlights that diabetes mellitus is associated with both an increased prevalence and an increased severity of COMISA.
The pathophysiology stems from a unique architecture of sleep disruption. Obstructive sleep apnea introduces acute intermittent hypoxia—repeated drops in blood oxygen saturation—which laboratory studies demonstrate impairs glucose metabolism even in awake, healthy volunteers. Meanwhile, the insomnia component adds its own metabolic burden. Layering short, fragmented sleep over cyclical hypoxemia may act synergistically on the sympathetic nervous system, the hypothalamic-pituitary-adrenal axis, and inflammatory pathways.
High blood sugar levels can trigger nocturia, neuropathic pain, and restless discomfort that break up sleep, whereas broken, oxygen-deprived sleep drives insulin resistance, appetite disruption stemming from modified leptin and ghrelin signaling, and weight gain, which consequently exacerbates both apnea severity and metabolic regulation.
| Sleep Disorder Phenotype | Overall Hazard Ratio for Incident Type 2 Diabetes | Male Hazard Elevation | Female Hazard Elevation |
|---|---|---|---|
| Insomnia Alone | 41% increased risk | 39% increase | 48% increase |
| Obstructive Sleep Apnea Alone | Not stated | >5x higher | ~4x higher |
| COMISA (Both Conditions) | 6.2x higher | 6.5x higher | 4.7x higher |
When to Consult a Doctor
The American Academy of Sleep Medicine recommends that adults experiencing symptoms of insomnia or sleep apnea seek evaluation from a sleep medicine clinician. Comprehensive screening and intervention are noted for their potential value as part of diabetes prevention efforts.
References
- Al Jumaily, K., et al. (2026). Insomnia, Sleep Apnea and Incident Diabetes Among U.S. Military Veterans. Abstract 1029, SLEEP 2026 Annual Meeting.
- Sankari, A. (2026). Journal of Clinical Sleep Medicine.
- American Academy of Sleep Medicine (AASM).
